In the Comsec Australian Market Wrap 7th March its section called Market Bulletin suggests taking an overweight position in Healthcare due to possible industry consolidation.
It terms an overweight position as a positive outlook for the sector.
Maybe consolidation of KSX with a industry partner may bring the commercial viability of its products a lot closer if they are are unable to secure it on their own.
Any one have a thought on this proposition?
IMO
KSX Price at posting:
0.0¢ Sentiment: ST Buy Disclosure: Held
